We are excited to announce our new collaborations

We are excited to share that Cures Within Reach for Cancer (now Reboot Rx) has launched multiple collaborations focused on building our evidence synthesis platform. We are using AI and machine learning to identify and synthesize data on non-cancer generic drugs being tested as cancer treatments. Our goal is to advance the most promising repurposed therapies to definitive clinical trials and into the standard of care.

With Innoplexus, we are using AI to search and connect large amounts of data to repurpose drugs. Data is being extracted from scientific publications, clinical trial information, conference abstracts, grants, and theses. Innoplexus is creating a continuously updated dashboard to help researchers quickly spot trends and be informed of pertinent new data in real-time. Learn more here.

With IBM Research, through its Science for Social Good Initiative, we are using natural language processing techniques to analyze scientific literature and uncover preclinical and early clinical research on repurposed therapies. We are also developing models that automatically capture key information about each paper, such as the type of cancer studied, the type of study conducted, and the nature of the evidence reported. Learn more here.

With Byron Wallace’s group at Northeastern University, we are leveraging their natural language processing and machine learning methods to synthesize evidence from randomized controlled trials. We are doing a deep dive into clinical trial data on repurposed therapies based on their experience with biomedical information extraction and hybrid machine learning and crowdsourcing approaches. Learn more here.

We are grateful to our partners for joining forces with us to apply the latest advances in AI and machine learning for real-world patient impact. We look forward to sharing our progress with you.